Biovail to Present at Barclays Capital Global Healthcare Conference

March 09, 2009

TORONTO--(BUSINESS WIRE)--Mar. 9, 2009-- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will present at the Barclays Capital Global Healthcare Conference at the Loews Miami Beach Hotel in Miami, Florida.

Biovail’s presentation is scheduled for Wednesday, March 11, 2009 at 4:15 p.m. EDT. A live and archived Webcast, in addition to presentation slides, will be available on the Investor Relations page of Biovail’s Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company’s Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].

Source: Biovail Corporation

Biovail Corporation
Nelson F. Isabel, (905) 286-3000
Vice President, Investor Relations & Corporate Communications

Powered by Sitecore